Combination treatment for metastatic melanoma results in longer overall survival

4 noviembre 2014

Among patients with metastatic melanoma, treatment with a combination of the drugs sargramostim plus ipilimumab, compared with ipilimumab alone, resulted in longer overall survival and lower toxicity, but no difference in progression-free survival, according to a study.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/GnmAJIh62c8/141104163019.htm

Volver